Skip to main content
Explore URMC

URMC Logo

menu

Lisa D. Reichman, M.D.

Publications

Showing all 83 journal articles & 9 books available

Journal Articles

4/15/2014
Vogler MA, Smeaton LM, Wright RL, Cardoso SW, Sanchez J, Infante R, Moran LE, Godfrey C, Demeter LM, Johnson VA. "Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227." Journal of acquired immune deficiency syndromes : JAIDS.. 2014 Apr 15; 65(5):542-50.

4/2013
Zhang X, Tierney C, Albrecht M, Demeter LM, Morse G, DiFrancesco R, Dykes C, Jiang H, Haas DW. "Discordant associations between SLCO1B1 521T?C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146." Therapeutic drug monitoring.. 2013 Apr 0; 35(2):209-16.

10/2011
Wang J, Zhang G, Bambara RA, Li D, Liang H, Wu H, Smith HM, Lowe NR, Demeter LM, Dykes C. "Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection." Journal of virology.. 2011 Oct 0; 85(20):10861-73. Epub 2011 Aug 10.

9/1/2011
Connick E, Bosch RJ, Aga E, Schlichtemeier R, Demeter LM, Volberding P, . "Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection." Journal of acquired immune deficiency syndromes : JAIDS.. 2011 Sep 1; 58(1):1-8.

2/20/2011
Piekna-Przybylska D, Dykes C, Demeter LM, Bambara RA. "Sequences in the U3 region of human immunodeficiency virus 1 improve efficiency of minus strand transfer in infected cells." Virology.. 2011 Feb 20; 410(2):368-74. Epub 2010 Dec 30.

2011
Albrecht M, Mukherjee AL, Tierney C, Morse GD, Dykes C, Klingman KL, Demeter LM. "A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study." HIV clinical trials.. 2011 12(4):201-14.

11/2010
Dykes C, Wu H, Sims M, Holden-Wiltse J, Demeter LM. "Human immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays." Journal of clinical microbiology.. 2010 Nov 0; 48(11):4035-43. Epub 2010 Sep 08.

9/1/2010
von Wyl V, Ehteshami M, Demeter LM, Bürgisser P, Nijhuis M, Symons J, Yerly S, Böni J, Klimkait T, Schuurman R, Ledergerber B, Götte M, Günthard HF, . "HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2010 Sep 1; 51(5):620-8.

9/2010
Wang J, Bambara RA, Dykes C. "Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions." Journal of virology.. 2010 Sep 0; 84(18):9377-89. Epub 2010 Jun 30.

9/2010
Dykes C, Mukherjee AL, Bosch RJ, Connick E, Volberding PA, Demeter LM. "Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371." Journal of acquired immune deficiency syndromes : JAIDS.. 2010 Sep 0; 55(1):132-4.

8/2010
Difrancesco R, Rosenkranz S, Mukherjee AL, Demeter LM, Jiang H, Dicenzo R, Dykes C, Rinehart A, Albrecht M, Morse GD. "Quality assessment for therapeutic drug monitoring in AIDS Clinical Trials Group (ACTG 5146): a multicenter clinical trial." Therapeutic drug monitoring.. 2010 Aug 0; 32(4):458-66.

7/5/2010
Wang J, Liang H, Bacheler L, Wu H, Deriziotis K, Demeter LM, Dykes C. "The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations." Virology.. 2010 Jul 5; 402(2):228-37. Epub 2010 Apr 18.

5/18/2010
Ma J, Dykes C, Wu T, Huang Y, Demeter L, Wu H. "vFitness: a web-based computing tool for improving estimation of in vitro HIV-1 fitness experiments." BMC bioinformatics. 2010 May 18; 11:261. Epub 2010 May 18.

4/1/2010
von Wyl V, Ehteshami M, Symons J, Bürgisser P, Nijhuis M, Demeter LM, Yerly S, Böni J, Klimkait T, Schuurman R, Ledergerber B, Götte M, Günthard HF, . "Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase." The Journal of infectious diseases.. 2010 Apr 1; 201(7):1054-62.

1/15/2010
Gandhi RT, Bosch RJ, Aga E, Albrecht M, Demeter LM, Dykes C, Bastow B, Para M, Lai J, Siliciano RF, Siliciano JD, Eron JJ, . "No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy." The Journal of infectious diseases.. 2010 Jan 15; 201(2):293-6.

2010
Hammer SM, Ribaudo H, Bassett R, Mellors JW, Demeter LM, Coombs RW, Currier J, Morse GD, Gerber JG, Martinez AI, Spreen W, Fischl MA, Squires KE, . "A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen." HIV clinical trials.. 2010 11(6):312-24.

9/24/2009
Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E, . "Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment." AIDS.. 2009 Sep 24; 23(15):1987-95.

3/2009
Miao H, Dykes C, Demeter LM, Wu H. "Differential equation modeling of HIV viral fitness experiments: model identification, model selection, and multimodel inference." Biometrics.. 2009 Mar 0; 65(1):292-300. Epub 2008 May 28.

1/28/2009
Demeter LM, Jiang H, Mukherjee AL, Morse GD, DiFrancesco R, DiCenzo R, Dykes C, Sista P, Bacheler L, Klingman K, Rinehart A, Albrecht M. "A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients." AIDS.. 2009 Jan 28; 23(3):357-68.

8/2008
Miao H, Dykes C, Demeter LM, Cavenaugh J, Park SY, Perelson AS, Wu H. "Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments." Bulletin of mathematical biology.. 2008 Aug 0; 70(6):1749-71. Epub 2008 Jul 22.

2008
Demeter LM, DeGruttola V, Lustgarten S, Bettendorf D, Fischl M, Eshleman S, Spreen W, Nguyen BY, Koval CE, Eron JJ, Hammer S, Squires K. "Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience." HIV clinical trials.. 2008 9(1):11-25.

2008
Demeter LM, Mukherjee AL, DiFrancesco R, Jiang H, DiCenzo R, Bastow B, Rinehart AR, Morse GD, Albrecht M. "The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients." HIV clinical trials.. 2008 9(1):61-72.

10/2007
Dykes C, Demeter LM. "Clinical significance of human immunodeficiency virus type 1 replication fitness." Clinical microbiology reviews.. 2007 Oct 0; 20(4):550-78.

1/30/2007
Fischl MA, Collier AC, Mukherjee AL, Feinberg JE, Demeter LM, Tebas P, Giuliano M, Dehlinger M, Garren K, Brizz B, Bassett R. "Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen." AIDS.. 2007 Jan 30; 21(3):325-33.

10/2006
Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W, . "HIV-1 viral load assays for resource-limited settings." PLoS medicine.. 2006 Oct 0; 3(10):e417.

9/15/2006
Koval CE, Dykes C, Wang J, Demeter LM. "Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V." Virology.. 2006 Sep 15; 353(1):184-92. Epub 2006 Jun 21.

8/15/2006
Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, Rose RC, Reichman RC. "Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York." The Journal of infectious diseases.. 2006 Aug 15; 194(4):428-34. Epub 2006 Jul 13.

8/1/2006
Domaoal RA, Bambara RA, Demeter LM. "HIV-1 reverse transcriptase mutants resistant to nonnucleoside reverse transcriptase inhibitors do not adversely affect DNA synthesis: pre-steady-state and steady-state kinetic studies." Journal of acquired immune deficiency syndromes : JAIDS.. 2006 Aug 1; 42(4):405-11.

6/2006
Dykes C, Wang J, Jin X, Planelles V, An DS, Tallo A, Huang Y, Wu H, Demeter LM. "Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture." Journal of clinical microbiology.. 2006 Jun 0; 44(6):1930-43.

5/10/2006
Wang J, Dykes C, Domaoal RA, Koval CE, Bambara RA, Demeter LM. "The HIV-1 reverse transcriptase mutants G190S and G190A, which confer resistance to non-nucleoside reverse transcriptase inhibitors, demonstrate reductions in RNase H activity and DNA synthesis from tRNA(Lys, 3) that correlate with reductions in replication efficiency." Virology.. 2006 May 10; 348(2):462-74. Epub 2006 Feb 28.

3/2006
Wu H, Huang Y, Dykes C, Liu D, Ma J, Perelson AS, Demeter LM. "Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay." Journal of virology.. 2006 Mar 0; 80(5):2380-9.

2/15/2006
Snyder-Cappione JE, Divekar AA, Maupin GM, Jin X, Demeter LM, Mosmann TR. "HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-gamma-secreting cells: anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responses." The Journal of immunology : official journal of the American Association of Immunologists.. 2006 Feb 15; 176(4):2662-8.

2006
Slish JC, Catanzaro LM, Ma Q, Okusanya OO, Demeter L, Albrecht M, Morse GD. "Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoring." Current pharmaceutical design.. 2006 12(9):1129-45.

9/1/2004
Dykes C, Balakrishnan M, Planelles V, Zhu Y, Bambara RA, Demeter LM. "Identification of a preferred region for recombination and mutation in HIV-1 gag." Virology.. 2004 Sep 1; 326(2):262-79.

9/2004
Domaoal RA, Demeter LM. "Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors." The international journal of biochemistry & cell biology.. 2004 Sep 0; 36(9):1735-51.

8/15/2004
Demeter LM, Ribaudo HJ, Erice A, Eshleman SH, Hammer SM, Hellmann NS, Fischl MA, . "HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2004 Aug 15; 39(4):552-8. Epub 2004 Jul 30.

6/2004
Jackson JB, Piwowar-Manning E, Johnson-Lewis L, Bassett R, Demeter LM, Brambilla D. "Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load." Journal of clinical microbiology.. 2004 Jun 0; 42(6):2774-6.

3/15/2004
Dykes C, Najjar J, Bosch RJ, Wantman M, Furtado M, Hart S, Hammer SM, Demeter LM. "Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine." The Journal of infectious diseases.. 2004 Mar 15; 189(6):1091-6. Epub 2004 Mar 01.

2004
Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD. "Update of the drug resistance mutations in HIV-1: 2004." Topics in HIV medicine : a publication of the International AIDS Society, USA. 2004 12(4):119-24.

12/2003
Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V, . "A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir." Antiviral therapy.. 2003 Dec 0; 8(6):507-18.

11/2003
Chadha KC, Schwartz SA, Nair MP, Demeter LR, Hewitt RG. "Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy." Immunological investigations.. 2003 Nov 0; 32(4):299-312.

9/1/2003
Fischl MA, Ribaudo HJ, Collier AC, Erice A, Giuliano M, Dehlinger M, Eron JJ, Saag MS, Hammer SM, Vella S, Morse GD, Feinberg JE, Demeter LM, Eshleman SH, . "A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease." The Journal of infectious diseases.. 2003 Sep 1; 188(5):625-34. Epub 2003 Aug 15.

7/1/2003
Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman DD. "Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2003 Jul 1; 37(1):113-28. Epub 2003 Jun 23.

2003
D'Aquila RT, Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. "Drug resistance mutations in HIV-1." Topics in HIV medicine : a publication of the International AIDS Society, USA. 2003 11(3):92-6.

2003
Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Richman DD, . "Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel." Topics in HIV medicine : a publication of the International AIDS Society, USA. 2003 11(4):150-4.

2003
Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD, . "Drug resistance mutations in HIV-1." Topics in HIV medicine : a publication of the International AIDS Society, USA. 2003 11(6):215-21.

8/15/2002
Koval CE, Gigliotti F, Nevins D, Demeter LM. "Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2002 Aug 15; 35(4):491-3. Epub 2002 Jul 24.

6/2002
Demeter LM, Bosch RJ, Coombs RW, Fiscus S, Bremer J, Johnson VA, Erice A, Jackson JB, Spector SA, Squires KM, Fischl MA, Hughes MD, Hammer SM. "Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter." Journal of clinical microbiology.. 2002 Jun 0; 40(6):2089-94.

2002
D'Aquila RT, , Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. "Drug Resistance Mutations in HIV-1." Topics in HIV medicine : a publication of the International AIDS Society, USA. 2002 10(5):21-25.

12/4/2001
Demeter LM, Hughes MD, Coombs RW, Jackson JB, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM. "Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320." Annals of internal medicine.. 2001 Dec 4; 135(11):954-64.

10/2001
Renda MJ, Rosenblatt JD, Klimatcheva E, Demeter LM, Bambara RA, Planelles V. "Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1." Journal of virology.. 2001 Oct 0; 75(20):9671-8.

7/5/2001
Dykes C, Fox K, Lloyd A, Chiulli M, Morse E, Demeter LM. "Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants." Virology.. 2001 Jul 5; 285(2):193-203.

5/15/2001
Evans TG, Bonnez W, Rose RC, Koenig S, Demeter L, Suzich JA, O'Brien D, Campbell M, White WI, Balsley J, Reichman RC. "A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers." The Journal of infectious diseases.. 2001 May 15; 183(10):1485-93. Epub 2001 Apr 24.

4/3/2001
Archer RH, Wisniewski M, Bambara RA, Demeter LM. "The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages." Biochemistry.. 2001 Apr 3; 40(13):4087-95.

3/1/2001
Demeter L, Haubrich R. "International perspectives on antiretroviral resistance. Phenotypic and genotypic resistance assays: methodology, reliability, and interpretations." Journal of acquired immune deficiency syndromes : JAIDS.. 2001 Mar 1; 26 Suppl 1:S3-9.

3/1/2001
Haubrich R, Demeter L. "International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations." Journal of acquired immune deficiency syndromes : JAIDS.. 2001 Mar 1; 26 Suppl 1:S51-9.

9/2000
Archer RH, Dykes C, Gerondelis P, Lloyd A, Fay P, Reichman RC, Bambara RA, Demeter LM. "Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture." Journal of virology.. 2000 Sep 0; 74(18):8390-401.

7/2000
Dykes C, Mootsikapun P, Dexter A, Berrios L, Chiulli M, Reichman RC, Demeter LM. "Analysis of env sequence evolution in human immunodeficiency virus-infected patients receiving therapy with nonnucleoside reverse-transcriptase inhibitors." The Journal of infectious diseases.. 2000 Jul 0; 182(1):316-20. Epub 2000 Jul 06.

7/2000
Schifitto G, McDermott MP, Evans T, Fitzgerald T, Schwimmer J, Demeter L, Kieburtz K. "Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: relationship to TH1 and TH2 cytokine profile." Archives of neurology.. 2000 Jul 0; 57(7):1027-32.

5/10/2000
Hirsch MS, Brun-Vézinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, Loveday C, Mellors JW, Clotet B, Conway B, Demeter LM, Vella S, Jacobsen DM, Richman DD. "Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel." JAMA.. 2000 May 10; 283(18):2417-26.

3/2000
Demeter LM, Shafer RW, Meehan PM, Holden-Wiltse J, Fischl MA, Freimuth WW, Para MF, Reichman RC. "Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)." Antimicrobial agents and chemotherapy.. 2000 Mar 0; 44(3):794-7.

1/2000
Morse GD, Reichman RC, Fischl MA, Para M, Leedom J, Powderly W, Demeter LM, Resnick L, Bassiakos Y, Timpone J, Cox S, Batts D. "Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams." Antiviral research.. 2000 Jan 0; 45(1):47-58.

8/1/1999
Friedland GH, Pollard R, Griffith B, Hughes M, Morse G, Bassett R, Freimuth W, Demeter L, Connick E, Nevin T, Hirsch M, Fischl M. "Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team." Journal of acquired immune deficiency syndromes : JAIDS.. 1999 Aug 1; 21(4):281-92.

7/1999
Gerondelis P, Archer RH, Palaniappan C, Reichman RC, Fay PJ, Bambara RA, Demeter LM. "The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities." Journal of virology.. 1999 Jul 0; 73(7):5803-13.

7/1999
Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, Boucher C. "Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase." Journal of clinical microbiology.. 1999 Jul 0; 37(7):2291-6.

6/1999
Luque AE, Demeter LM, Reichman RC. "Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection." The Journal of infectious diseases.. 1999 Jun 0; 179(6):1405-9.

6/1999
Para MF, Meehan P, Holden-Wiltse J, Fischl M, Morse G, Shafer R, Demeter LM, Wood K, Nevin T, Virani-Ketter N, Freimuth WW. "ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 Team." Antimicrobial agents and chemotherapy.. 1999 Jun 0; 43(6):1373-8.

11/1998
Demeter LM, D'Aquila R, Weislow O, Lorenzo E, Erice A, Fitzgibbon J, Shafer R, Richman D, Howard TM, Zhao Y, Fisher E, Huang D, Mayers D, Sylvester S, Arens M, Sannerud K, Rasheed S, Johnson V, Kuritzkes D, Reichelderfer P, Japour A. "Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group." Journal of virological methods.. 1998 Nov 0; 75(1):93-104.

10/1/1998
Demeter LM, Meehan PM, Morse G, Fischl MA, Para M, Powderly W, Leedom J, Holden-Wiltse J, Greisberger C, Wood K, Timpone J, Wathen LK, Nevin T, Resnick L, Batts DH, Reichman RC. "Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1998 Oct 1; 19(2):135-44.

6/24/1998
Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vézinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM, Kuritzkes DR, Loveday C, Mellors JW, Vella S, Richman DD. "Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel." JAMA.. 1998 Jun 24; 279(24):1984-91.

9/11/1997
Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Deyton LR, Chodakewitz JA, Fischl MA. "A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team." The New England journal of medicine.. 1997 Sep 11; 337(11):725-33.

2/1/1997
Demeter LM, Meehan PM, Morse G, Gerondelis P, Dexter A, Berrios L, Cox S, Freimuth W, Reichman RC. "HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1997 Feb 1; 14(2):136-44.

2/1997
Paxton WB, Coombs RW, McElrath MJ, Keefer MC, Hughes J, Sinangil F, Chernoff D, Demeter L, Williams B, Corey L. "Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group." The Journal of infectious diseases.. 1997 Feb 0; 175(2):247-54.

10/1996
Welles SL, Jackson JB, Yen-Lieberman B, Demeter L, Japour AJ, Smeaton LM, Johnson VA, Kuritzkes DR, D'Aquila RT, Reichelderfer PA, Richman DD, Reichman R, Fischl M, Dolin R, Coombs RW, Kahn JO, McLaren C, Todd J, Kwok S, Crumpacker CS. "Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team." The Journal of infectious diseases.. 1996 Oct 0; 174(4):696-703.

1996
Bonnez W, Oakes D, Choi A, d'Arcy SJ, Pappas PG, Corey L, Stoler MH, Demeter LM, Reichman RC. "Therapeutic efficacy and complications of excisional biopsy of condyloma acuminatum." Sexually transmitted diseases.. 1996 23(4):273-6.

12/1995
Demeter LM, Nawaz T, Morse G, Dolin R, Dexter A, Gerondelis P, Reichman RC. "Development of zidovudine resistance mutations in patients receiving prolonged didanosine monotherapy." The Journal of infectious diseases.. 1995 Dec 0; 172(6):1480-5.

5/1995
Frenkel LM, Wagner LE, Demeter LM, Dewhurst S, Coombs RW, Murante BL, Reichman RC. "Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 1995 May 0; 20(5):1321-6.

2/1995
Reichman RC, Morse GD, Demeter LM, Resnick L, Bassiakos Y, Fischl M, Para M, Powderly W, Leedom J, Greisberger C. "Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team." The Journal of infectious diseases.. 1995 Feb 0; 171(2):297-304.

4/1994
Demeter LM, Stoler MH, Broker TR, Chow LT. "Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions." Human pathology.. 1994 Apr 0; 25(4):343-8.

7/1993
Demeter LM, Stoler MH, Bonnez W, Corey L, Pappas P, Strussenberg J, Reichman RC. "Penile intraepithelial neoplasia: clinical presentation and an analysis of the physical state of human papillomavirus DNA." The Journal of infectious diseases.. 1993 Jul 0; 168(1):38-46.

7/1992
Dollard SC, Wilson JL, Demeter LM, Bonnez W, Reichman RC, Broker TR, Chow LT. "Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF." Genes & development.. 1992 Jul 0; 6(7):1131-42.

3/15/1992
Demeter LM, Stoler MH, Sobel ME, Broker TR, Chow LT. "Expression of high-affinity laminin receptor mRNA correlates with cell proliferation rather than invasion in human papillomavirus-associated cervical neoplasms." Cancer research.. 1992 Mar 15; 52(6):1561-7.

12/1990
Reichman RC, Oakes D, Bonnez W, Brown D, Mattison HR, Bailey-Farchione A, Stoler MH, Demeter LM, Tyring SK, Miller L. "Treatment of condyloma acuminatum with three different interferon-alpha preparations administered parenterally: a double-blind, placebo-controlled trial." The Journal of infectious diseases.. 1990 Dec 0; 162(6):1270-6.

Books & Chapters

2006
Chapter Title: Delavirdine
Book Title: AIDS Therapy
Author List: Demeter LM, Reichman RC
Edited By: Dolin R, Masur H, Saag M
Published By: Churchill Livingstone2006 in New York

2005
Chapter Title: JC, BK, and other polyomaviruses; Progressive multifocal leukoencephalopathy
Book Title: Principles and Practice of Infectious Diseases
Author List: Demeter LM
Edited By: Mandell GL, Bennet JE, Dolin R
Published By: Churchill Livingstone2005 in New York

2000
Chapter Title: Delavirdine
Book Title: AIDS Therapy
Author List: Demeter LM, Reichman RC
Edited By: Dolin R, Masur H, Saag M
Published By: Churchill Livingstone2000 in New York

2000
Chapter Title: Detection of HIV infection
Book Title: Principles and Practice of Infectious Diseases
Author List: Demeter LM, Reichman RC
Edited By: Mandell GL, Bennett JE, Dolin R
Published By: Churchill Livingstone2000 in New York

2000
Chapter Title: JC, BK, and other polyomaviruses; Progressive multifocal leukoencephalopathy
Book Title: Principles and Practice of Infectious Diseases
Author List: Demeter LM
Edited By: Mandell GL, Bennett JE, Dolin R
Published By: Churchill Livingstone2000 in New York

1999
Chapter Title: Delavirdine
Book Title: AIDS Therapy
Author List: Demeter LM, Reichman RC
Edited By: Dolin R, Masur H, Saag M
Published By: Churchill Livingstone1999 in New York

1995
Chapter Title: JC, BK, and other polyomaviruses; Progressive multifocal leukoencephalopathy
Book Title: Principles and Practice of Infectious Diseases
Author List: Demeter LM
Edited By: Mandell GL, Bennett JE, Dolin R
Published By: Churchill Livingstone1995 in New York

1994
Chapter Title: Association of human papillomaviruses with other female genital tract tumors
Book Title: Genital Warts--Human Papillomavirus Infection
Author List: Demeter LM, Reichman RC
Edited By: Mindel A
Published By: Edward Arnold Publishers, Ltd.1994 in London

1993
Chapter Title: Diagnosis of anogenital human papillomavirus infections
Book Title: Practical Diagnosis of Viral infections
Author List: Demeter LM, Reichman RC
Edited By: Galasso GJ, Whitley RJ, Merigan TC
Published By: Raven Press1993 in New York